# Vir Biotechnology, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:ea6765c2-1439-4f2f-adb3-5181ccaae732 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/vir-biotechnology-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 31 | | Claims under review | 1 | | Evidence records | 7 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-27T04:46:09.561966+00:00 | | Last reviewed | 2026-10-27T04:46:09.561966+00:00 | ## Identity - Legal name: Vir Biotechnology, Inc. - Display name: Vir Biotechnology, Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-27T04:46:09.561966+00:00 | | Completeness | 0.409 | | Record Quality | 0.836 | | Directors | 7 | | Committees | 4 | | Governance events | 11 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Elliott Sigal: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2020-01-01. Committees: Compensation Committee (member); Science and Technology Committee (chair). claim_id=alpha:claim:company:ea6765c2-1439-4f2f-adb3-5181ccaae732:leadership_role:5 - Janet Napolitano: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2020-01-01. Committees: Compensation Committee (member); Nominating and Corporate Governance Committee (member). claim_id=alpha:claim:company:ea6765c2-1439-4f2f-adb3-5181ccaae732:leadership_role:6 - Jeffrey S. Hatfield: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2020-01-01. Committees: Audit Committee (member); Nominating and Corporate Governance Committee (chair). claim_id=alpha:claim:company:ea6765c2-1439-4f2f-adb3-5181ccaae732:leadership_role:7 - Marianne De Backer: Director. Status: current. Independent: false. Since: 2023-01-01. claim_id=alpha:claim:company:ea6765c2-1439-4f2f-adb3-5181ccaae732:leadership_role:8 - Norbert Bischofberger: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2024-01-01. Committees: Compensation Committee (member); Science and Technology Committee (member). claim_id=alpha:claim:company:ea6765c2-1439-4f2f-adb3-5181ccaae732:leadership_role:9 - Ramy Farid: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2024-01-01. Committees: Audit Committee (member); Science and Technology Committee (member). claim_id=alpha:claim:company:ea6765c2-1439-4f2f-adb3-5181ccaae732:leadership_role:10 - Robert More: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2016-01-01. Committees: Audit Committee (member); Compensation Committee (chair). claim_id=alpha:claim:company:ea6765c2-1439-4f2f-adb3-5181ccaae732:leadership_role:11 ## Committees - Audit Committee (audit). Chair: NOT_PUBLISHED. Members: Jeffrey S. Hatfield (member, current); Ramy Farid (member, current); Robert More (member, current). committee_id=alpha:committee:vir-biotechnology-inc:audit-committee - Compensation Committee (compensation). Chair: Robert More. Members: Robert More (chair, current); Elliott Sigal (member, current); Janet Napolitano (member, current); Norbert Bischofberger (member, current). committee_id=alpha:committee:vir-biotechnology-inc:compensation-committee - Nominating and Corporate Governance Committee (nominating_governance). Chair: Jeffrey S. Hatfield. Members: Jeffrey S. Hatfield (chair, current); Janet Napolitano (member, current). committee_id=alpha:committee:vir-biotechnology-inc:nominating-and-corporate-governance-committee - Science and Technology Committee (technology). Chair: Elliott Sigal. Members: Elliott Sigal (chair, current); Norbert Bischofberger (member, current); Ramy Farid (member, current). committee_id=alpha:committee:vir-biotechnology-inc:science-and-technology-committee ## Executive leadership - Brent Sabatini: Senior Vice President, Finance and Chief Accounting Officer [CAO]. Status: current. claim_id=alpha:claim:company:ea6765c2-1439-4f2f-adb3-5181ccaae732:leadership_role:12 - Jason O'Byrne: Executive Vice President and Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:ea6765c2-1439-4f2f-adb3-5181ccaae732:leadership_role:13 - Marianne De Backer: Chief Executive Officer and Director [CEO]. Status: current. claim_id=alpha:claim:company:ea6765c2-1439-4f2f-adb3-5181ccaae732:leadership_role:14 - Vanina de Verneuil: General Counsel [GC]. Status: current. claim_id=alpha:claim:company:ea6765c2-1439-4f2f-adb3-5181ccaae732:leadership_role:15 ## Governance events - EXECUTIVE_APPOINTED: Brent Sabatini executive of Vir Biotechnology, Inc., effective 2026-02-23. Effective: 2026-02-23. Detected: 2026-10-27T04:46:09.561966+00:00. event_id=alpha:event:transition:6b4skv605569 - CFO_CHANGED: Jason O'Byrne executive of Vir Biotechnology, Inc., effective 2026-02-23. Effective: 2026-02-23. Detected: 2026-10-27T04:46:09.561966+00:00. event_id=alpha:event:transition:jhaco4ohyw9i - CEO_CHANGED: Marianne De Backer executive of Vir Biotechnology, Inc., effective 2026-02-23. Effective: 2026-02-23. Detected: 2026-10-27T04:46:09.561966+00:00. event_id=alpha:event:transition:za3dgsomq3qa - GC_CHANGED: Vanina de Verneuil executive of Vir Biotechnology, Inc., effective 2026-02-23. Effective: 2026-02-23. Detected: 2026-10-27T04:46:09.561966+00:00. event_id=alpha:event:transition:15hi4eh1safovz - DIRECTOR_APPOINTED: Norbert Bischofberger seat on Vir Biotechnology, Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-27T04:46:09.561966+00:00. event_id=alpha:event:transition:tuhvnp9t0e3b - DIRECTOR_APPOINTED: Ramy Farid seat on Vir Biotechnology, Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-27T04:46:09.561966+00:00. event_id=alpha:event:transition:9zxpizv5gaur - DIRECTOR_APPOINTED: Marianne De Backer seat on Vir Biotechnology, Inc., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-27T04:46:09.561966+00:00. event_id=alpha:event:transition:19d5on11igdfgd - DIRECTOR_APPOINTED: Elliott Sigal seat on Vir Biotechnology, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-27T04:46:09.561966+00:00. event_id=alpha:event:transition:otznaleakhwf - DIRECTOR_APPOINTED: Janet Napolitano seat on Vir Biotechnology, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-27T04:46:09.561966+00:00. event_id=alpha:event:transition:13nvk4wj59sbk - DIRECTOR_APPOINTED: Jeffrey S. Hatfield seat on Vir Biotechnology, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-27T04:46:09.561966+00:00. event_id=alpha:event:transition:1482ajn81hstx - DIRECTOR_APPOINTED: Robert More seat on Vir Biotechnology, Inc., effective 2016-01-01. Effective: 2016-01-01. Detected: 2026-10-27T04:46:09.561966+00:00. event_id=alpha:event:transition:ufkysx1raxynj ## Scoped resources - `alpha://company/vir-biotechnology-inc` (contract): https://registry.alpha.ac/api/public/companies/vir-biotechnology-inc?format=record - `alpha://company/vir-biotechnology-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/vir-biotechnology-inc?format=record§ion=identity - `alpha://company/vir-biotechnology-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/vir-biotechnology-inc?format=record§ion=corporate-structure - `alpha://company/vir-biotechnology-inc/board` (contract): https://registry.alpha.ac/api/public/companies/vir-biotechnology-inc?format=record§ion=board - `alpha://company/vir-biotechnology-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/vir-biotechnology-inc?format=record§ion=committees - `alpha://company/vir-biotechnology-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/vir-biotechnology-inc?format=record§ion=leadership - `alpha://company/vir-biotechnology-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/vir-biotechnology-inc?format=record§ion=ownership - `alpha://company/vir-biotechnology-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/vir-biotechnology-inc?format=record§ion=financials - `alpha://company/vir-biotechnology-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/vir-biotechnology-inc?format=record§ion=capital-structure - `alpha://company/vir-biotechnology-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/vir-biotechnology-inc?format=record§ion=compensation - `alpha://company/vir-biotechnology-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/vir-biotechnology-inc?format=record§ion=governance - `alpha://company/vir-biotechnology-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/vir-biotechnology-inc?format=record§ion=shareholder-governance - `alpha://company/vir-biotechnology-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/vir-biotechnology-inc?format=record§ion=audit - `alpha://company/vir-biotechnology-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/vir-biotechnology-inc?format=record§ion=legal - `alpha://company/vir-biotechnology-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/vir-biotechnology-inc?format=record§ion=risk - `alpha://company/vir-biotechnology-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/vir-biotechnology-inc?format=record§ion=cyber - `alpha://company/vir-biotechnology-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/vir-biotechnology-inc?format=record§ion=ai-governance - `alpha://company/vir-biotechnology-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/vir-biotechnology-inc?format=record§ion=agents - `alpha://company/vir-biotechnology-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/vir-biotechnology-inc?format=record§ion=ecosystem - `alpha://company/vir-biotechnology-inc/events` (contract): https://registry.alpha.ac/api/public/companies/vir-biotechnology-inc?format=record§ion=events - `alpha://company/vir-biotechnology-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/vir-biotechnology-inc?format=record§ion=relationships - `alpha://company/vir-biotechnology-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/vir-biotechnology-inc?format=record§ion=assessments - `alpha://company/vir-biotechnology-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/vir-biotechnology-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:ea6765c2-1439-4f2f-adb3-5181ccaae732:committee_appointment:17: `{"kind":"committee_appointment","original_name":"Audit Committee","category":"audit","role":"member","person":{"alpha_id":"alpha:person:jeffrey-s-hatfield-vir","name":"Jeffrey S. Hatfield"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:ea6765c2-1439-4f2f-adb3-5181ccaae732:committee_appointment:18: `{"kind":"committee_appointment","original_name":"Audit Committee","category":"audit","role":"member","person":{"alpha_id":"alpha:person:ramy-farid-vir","name":"Ramy Farid"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:ea6765c2-1439-4f2f-adb3-5181ccaae732:committee_appointment:19: `{"kind":"committee_appointment","original_name":"Audit Committee","category":"audit","role":"member","person":{"alpha_id":"alpha:person:robert-more-vir","name":"Robert More"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:ea6765c2-1439-4f2f-adb3-5181ccaae732:committee_appointment:21: `{"kind":"committee_appointment","original_name":"Compensation Committee","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:robert-more-vir","name":"Robert More"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:ea6765c2-1439-4f2f-adb3-5181ccaae732:committee_appointment:22: `{"kind":"committee_appointment","original_name":"Compensation Committee","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:elliott-sigal-vir","name":"Elliott Sigal"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:ea6765c2-1439-4f2f-adb3-5181ccaae732:committee_appointment:23: `{"kind":"committee_appointment","original_name":"Compensation Committee","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:janet-napolitano-vir","name":"Janet Napolitano"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:ea6765c2-1439-4f2f-adb3-5181ccaae732:committee_appointment:24: `{"kind":"committee_appointment","original_name":"Compensation Committee","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:norbert-bischofberger-vir","name":"Norbert Bischofberger"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:ea6765c2-1439-4f2f-adb3-5181ccaae732:committee_appointment:26: `{"kind":"committee_appointment","original_name":"Nominating and Corporate Governance Committee","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:jeffrey-s-hatfield-vir","name":"Jeffrey S. Hatfield"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:ea6765c2-1439-4f2f-adb3-5181ccaae732:committee_appointment:27: `{"kind":"committee_appointment","original_name":"Nominating and Corporate Governance Committee","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:janet-napolitano-vir","name":"Janet Napolitano"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:ea6765c2-1439-4f2f-adb3-5181ccaae732:committee_appointment:29: `{"kind":"committee_appointment","original_name":"Science and Technology Committee","category":"technology","role":"chair","person":{"alpha_id":"alpha:person:elliott-sigal-vir","name":"Elliott Sigal"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:ea6765c2-1439-4f2f-adb3-5181ccaae732:committee_appointment:30: `{"kind":"committee_appointment","original_name":"Science and Technology Committee","category":"technology","role":"member","person":{"alpha_id":"alpha:person:norbert-bischofberger-vir","name":"Norbert Bischofberger"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:ea6765c2-1439-4f2f-adb3-5181ccaae732:committee_appointment:31: `{"kind":"committee_appointment","original_name":"Science and Technology Committee","category":"technology","role":"member","person":{"alpha_id":"alpha:person:ramy-farid-vir","name":"Ramy Farid"},"source_id":"governance_people_committees"}` ## Leadership - Elliott Sigal: Director. Claim: alpha:claim:company:ea6765c2-1439-4f2f-adb3-5181ccaae732:leadership_role:5. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b4ee3634d14542fd0b6ac220944ec787069726a1e231bc2559168a54a27f152c. - Janet Napolitano: Director. Claim: alpha:claim:company:ea6765c2-1439-4f2f-adb3-5181ccaae732:leadership_role:6. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b4ee3634d14542fd0b6ac220944ec787069726a1e231bc2559168a54a27f152c. - Jeffrey S. Hatfield: Director. Claim: alpha:claim:company:ea6765c2-1439-4f2f-adb3-5181ccaae732:leadership_role:7. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b4ee3634d14542fd0b6ac220944ec787069726a1e231bc2559168a54a27f152c. - Marianne De Backer: Director. Claim: alpha:claim:company:ea6765c2-1439-4f2f-adb3-5181ccaae732:leadership_role:8. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b4ee3634d14542fd0b6ac220944ec787069726a1e231bc2559168a54a27f152c. - Norbert Bischofberger: Director. Claim: alpha:claim:company:ea6765c2-1439-4f2f-adb3-5181ccaae732:leadership_role:9. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b4ee3634d14542fd0b6ac220944ec787069726a1e231bc2559168a54a27f152c. - Ramy Farid: Director. Claim: alpha:claim:company:ea6765c2-1439-4f2f-adb3-5181ccaae732:leadership_role:10. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b4ee3634d14542fd0b6ac220944ec787069726a1e231bc2559168a54a27f152c. - Robert More: Director. Claim: alpha:claim:company:ea6765c2-1439-4f2f-adb3-5181ccaae732:leadership_role:11. Valid from: 2016-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b4ee3634d14542fd0b6ac220944ec787069726a1e231bc2559168a54a27f152c. - Brent Sabatini: Senior Vice President, Finance and Chief Accounting Officer. Claim: alpha:claim:company:ea6765c2-1439-4f2f-adb3-5181ccaae732:leadership_role:12. Valid from: 2026-02-23. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:dcad7354bbc0406e2046ae4b429e34eba34b1e0c51c3a4c3dff781f1eb0de28c. - Jason O'Byrne: Executive Vice President and Chief Financial Officer. Claim: alpha:claim:company:ea6765c2-1439-4f2f-adb3-5181ccaae732:leadership_role:13. Valid from: 2026-02-23. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:04e0a4fc6c3a5398b5e929bd74ce8c1ef74005d36d2392e44c31a81ad0934e14. - Marianne De Backer: Chief Executive Officer and Director. Claim: alpha:claim:company:ea6765c2-1439-4f2f-adb3-5181ccaae732:leadership_role:14. Valid from: 2026-02-23. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:cc586261e9b3cd5957f1b2ae755c502387f5e0ecc465a0be13d0c09b6c608aa7. - Vanina de Verneuil: General Counsel. Claim: alpha:claim:company:ea6765c2-1439-4f2f-adb3-5181ccaae732:leadership_role:15. Valid from: 2026-02-23. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:19e656417e7ac42101fa41fdbfe80abc394b77370f46439b1184893392714f1d. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit Committee: Chair not stated; Members Jeffrey S. Hatfield; Ramy Farid; Robert More. Claim: alpha:claim:company:ea6765c2-1439-4f2f-adb3-5181ccaae732:committee_record:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dc1731f51afdb321b2a07cee4fe1220cbb7bfc430734b398cb978a4d43940215. - Compensation Committee: Chair Robert More; Members Robert More (Chair); Elliott Sigal; Janet Napolitano; Norbert Bischofberger. Claim: alpha:claim:company:ea6765c2-1439-4f2f-adb3-5181ccaae732:committee_record:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dc1731f51afdb321b2a07cee4fe1220cbb7bfc430734b398cb978a4d43940215. - Nominating and Corporate Governance Committee: Chair Jeffrey S. Hatfield; Members Jeffrey S. Hatfield (Chair); Janet Napolitano. Claim: alpha:claim:company:ea6765c2-1439-4f2f-adb3-5181ccaae732:committee_record:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dc1731f51afdb321b2a07cee4fe1220cbb7bfc430734b398cb978a4d43940215. - Science and Technology Committee: Chair Elliott Sigal; Members Elliott Sigal (Chair); Norbert Bischofberger; Ramy Farid. Claim: alpha:claim:company:ea6765c2-1439-4f2f-adb3-5181ccaae732:committee_record:28. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dc1731f51afdb321b2a07cee4fe1220cbb7bfc430734b398cb978a4d43940215. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Vir Biotechnology, Inc.. Claim: alpha:claim:company:ea6765c2-1439-4f2f-adb3-5181ccaae732:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:740bc83b9cfe39386cf094412b6da304d93942768e03d424e0946cec5ca190de. ## Entity Status - Public listing published. Claim: alpha:claim:company:ea6765c2-1439-4f2f-adb3-5181ccaae732:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:740bc83b9cfe39386cf094412b6da304d93942768e03d424e0946cec5ca190de. ## Published Fact - US. Claim: alpha:claim:company:ea6765c2-1439-4f2f-adb3-5181ccaae732:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:740bc83b9cfe39386cf094412b6da304d93942768e03d424e0946cec5ca190de. ## Committee Appointment - Jeffrey S. Hatfield: member, Audit Committee. Claim: alpha:claim:company:ea6765c2-1439-4f2f-adb3-5181ccaae732:committee_appointment:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dc1731f51afdb321b2a07cee4fe1220cbb7bfc430734b398cb978a4d43940215. - Ramy Farid: member, Audit Committee. Claim: alpha:claim:company:ea6765c2-1439-4f2f-adb3-5181ccaae732:committee_appointment:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dc1731f51afdb321b2a07cee4fe1220cbb7bfc430734b398cb978a4d43940215. - Robert More: member, Audit Committee. Claim: alpha:claim:company:ea6765c2-1439-4f2f-adb3-5181ccaae732:committee_appointment:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dc1731f51afdb321b2a07cee4fe1220cbb7bfc430734b398cb978a4d43940215. - Robert More: chair, Compensation Committee. Claim: alpha:claim:company:ea6765c2-1439-4f2f-adb3-5181ccaae732:committee_appointment:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dc1731f51afdb321b2a07cee4fe1220cbb7bfc430734b398cb978a4d43940215. - Elliott Sigal: member, Compensation Committee. Claim: alpha:claim:company:ea6765c2-1439-4f2f-adb3-5181ccaae732:committee_appointment:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dc1731f51afdb321b2a07cee4fe1220cbb7bfc430734b398cb978a4d43940215. - Janet Napolitano: member, Compensation Committee. Claim: alpha:claim:company:ea6765c2-1439-4f2f-adb3-5181ccaae732:committee_appointment:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dc1731f51afdb321b2a07cee4fe1220cbb7bfc430734b398cb978a4d43940215. - Norbert Bischofberger: member, Compensation Committee. Claim: alpha:claim:company:ea6765c2-1439-4f2f-adb3-5181ccaae732:committee_appointment:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dc1731f51afdb321b2a07cee4fe1220cbb7bfc430734b398cb978a4d43940215. - Jeffrey S. Hatfield: chair, Nominating and Corporate Governance Committee. Claim: alpha:claim:company:ea6765c2-1439-4f2f-adb3-5181ccaae732:committee_appointment:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dc1731f51afdb321b2a07cee4fe1220cbb7bfc430734b398cb978a4d43940215. - Janet Napolitano: member, Nominating and Corporate Governance Committee. Claim: alpha:claim:company:ea6765c2-1439-4f2f-adb3-5181ccaae732:committee_appointment:27. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dc1731f51afdb321b2a07cee4fe1220cbb7bfc430734b398cb978a4d43940215. - Elliott Sigal: chair, Science and Technology Committee. Claim: alpha:claim:company:ea6765c2-1439-4f2f-adb3-5181ccaae732:committee_appointment:29. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dc1731f51afdb321b2a07cee4fe1220cbb7bfc430734b398cb978a4d43940215. - Norbert Bischofberger: member, Science and Technology Committee. Claim: alpha:claim:company:ea6765c2-1439-4f2f-adb3-5181ccaae732:committee_appointment:30. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dc1731f51afdb321b2a07cee4fe1220cbb7bfc430734b398cb978a4d43940215. - Ramy Farid: member, Science and Technology Committee. Claim: alpha:claim:company:ea6765c2-1439-4f2f-adb3-5181ccaae732:committee_appointment:31. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dc1731f51afdb321b2a07cee4fe1220cbb7bfc430734b398cb978a4d43940215. ## Security Listing - VIR (NASDAQ). Claim: alpha:claim:company:ea6765c2-1439-4f2f-adb3-5181ccaae732:security_listing:32. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:740bc83b9cfe39386cf094412b6da304d93942768e03d424e0946cec5ca190de. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:740bc83b9cfe39386cf094412b6da304d93942768e03d424e0946cec5ca190de: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/vir-biotechnology-inc). - alpha:projection-evidence:document:b4ee3634d14542fd0b6ac220944ec787069726a1e231bc2559168a54a27f152c: [DEF 14A vir-20260415.htm](https://www.sec.gov/Archives/edgar/data/1706431/000162828026025379/vir-20260415.htm). - alpha:projection-evidence:document:dcad7354bbc0406e2046ae4b429e34eba34b1e0c51c3a4c3dff781f1eb0de28c: [VIR 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1706431/000162828026010749/vir-20251231.htm). - alpha:projection-evidence:document:04e0a4fc6c3a5398b5e929bd74ce8c1ef74005d36d2392e44c31a81ad0934e14: [VIR 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1706431/000162828026010749/vir-20251231.htm). - alpha:projection-evidence:document:cc586261e9b3cd5957f1b2ae755c502387f5e0ecc465a0be13d0c09b6c608aa7: [VIR 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1706431/000162828026010749/vir-20251231.htm). - alpha:projection-evidence:document:19e656417e7ac42101fa41fdbfe80abc394b77370f46439b1184893392714f1d: [VIR 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1706431/000162828026010749/vir-20251231.htm). - alpha:projection-evidence:dc1731f51afdb321b2a07cee4fe1220cbb7bfc430734b398cb978a4d43940215: [Audit Committee](https://www.sec.gov/Archives/edgar/data/1706431/000162828026025379/vir-20260415.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/vir-biotechnology-inc) - [Public Markdown](https://registry.alpha.ac/companies/vir-biotechnology-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/vir-biotechnology-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/vir-biotechnology-inc?format=jsonld) - MCP resource: `alpha://companies/vir-biotechnology-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Structured intelligence is not currently available. Existing published profile evidence remains accessible. ## Critical-risk oversight Snapshot as of 2026-10-27T07:21:39.874131+00:00; recorded 2026-10-27T07:21:39.874131+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.